Skip to content

Clinical trials

Completed Fallopian Tube Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Status: Completed Country / region: Belgium Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20093
20104
20123
20141
20162
20171
20182
20194
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
ImmunoGen, Inc.3
AbbVie2
Eli Lilly and Company2
European Organisation for Research and Treatment of Cancer - EORTC2
AGO Study Group1
Belgian Gynaecological Oncology Group1
Bristol-Myers Squibb1
Corcept Therapeutics1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms28
Ovarian Neoplasms24
Carcinoma, Ovarian Epithelial12
Peritoneal Neoplasms5
Neoplasms3
Carcinoma2
Endocrine System Diseases1
Endometrial Neoplasms1
Fallopian Tube Diseases1
Genital Diseases, Female1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.